Reply.

Ted R Mikuls Liana FraenkelEllen GravalleseSindhu R Johnson Amy S TurnerKenneth G Saag

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)

We appreciate the thoughtful suggestions provided by Bansal and colleagues regarding the American College of Rheumatology (ACR) Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic [1]. While there are noteworthy strengths to the ACR-led effort, we recognize that the guidance generated is not comprehensive, as it does not address all of the potential scenarios or treatments relevant to the day-to-day management of rheumatic disease (RD) patients.

Keyphrases

end stage renal disease
rheumatoid arthritis
ejection fraction
chronic kidney disease
newly diagnosed
climate change
prognostic factors
peritoneal dialysis
patient reported outcomes
risk assessment
juvenile idiopathic arthritis